We are live on ! Find out more
DPLO

DIPLOMAT PHARMACY, INC.
DPLO

Delisted

DPLO was delisted on the 7th of February, 2020.

101 hedge funds and large institutions have $1.01B invested in DIPLOMAT PHARMACY, INC. in 2015 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 37 increasing their positions, 25 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

240% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 10

103% more capital invested

Capital invested by funds: $497M → $1.01B (+$511M)

48% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 25

31% more funds holding

Funds holding: 77101 (+24)

12% more call options, than puts

Call options by funds: $2.31M | Put options by funds: $2.06M

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
101
Holders Change
+24
Holders Change %
+31.17%
% of All Funds
2.69%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
34
Increased
37
Reduced
25
Closed
10
Calls
$2.31M
Puts
$2.06M
Net Calls
+$241K
Net Calls Change
+$241K
Name Holding Trade Value Shares
Change
Change in
Stake
LCM
76
Landscape Capital Management
New Jersey
$318K +$250K +9,188 New
VOYA Investment Management
77
VOYA Investment Management
Georgia
$292K
MAA
78
Managed Account Advisors
New Jersey
$286K +$209K +7,692 +1,308%
IRS
79
Invictus RG (Singapore)
Singapore
$260K +$204K +7,508 New
USAA
80
United Services Automobile Association
Texas
$249K -$331K -12,160 -63%
FMT
81
First Mercantile Trust
Tennessee
$244K +$192K +7,050 New
YMRC
82
Yorktown Management & Research Company
Virginia
$242K +$190K +7,000 New
DT
83
Diversified Trust
Tennessee
$234K +$184K +6,775 New
William Blair & Company
84
William Blair & Company
Illinois
$232K +$183K +6,735 New
GCP
85
GSA Capital Partners
United Kingdom
$225K +$177K +6,500 New
TRCT
86
Tower Research Capital (TRC)
New York
$188K +$143K +5,244 +2,622%
Bank of Montreal
87
Bank of Montreal
Ontario, Canada
$169K +$133K +4,900 New
BG
88
BlackRock Group
United Kingdom
$134K -$1.18M -43,279 -92%
SG Americas Securities
89
SG Americas Securities
New York
$112K +$88.1K +3,237 New
Legal & General Group
90
Legal & General Group
United Kingdom
$97K +$62.2K +2,284 +442%
QT
91
Quantbot Technologies
New York
$50K +$39.7K +1,460 New
Citigroup
92
Citigroup
New York
$41K -$48.7K -1,791 -60%
BlackRock
93
BlackRock
New York
$38K -$9.01K -331 -23%
Citadel Advisors
94
Citadel Advisors
Florida
$36K +$28.2K +1,035 New
BBHC
95
Brown Brothers Harriman & Co
New York
$35K
Barclays
96
Barclays
United Kingdom
$30K -$2.45K -90 -10%
BJ
97
BlackRock Japan
Japan
$29K -$73.2K -2,689 -76%
Royal Bank of Canada
98
Royal Bank of Canada
Ontario, Canada
$17K -$431K -15,839 -97%
Fifth Third Bancorp
99
Fifth Third Bancorp
Ohio
$17K +$13.6K +500 New
BNP Paribas Financial Markets
100
BNP Paribas Financial Markets
France
$12.7K +$9.99K +367 New

DPLO Hedge Fund Activity: Q1 2015 in Review

101 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q1 2015, worth a combined $1.01B — up 103% from $497M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new DPLO positions and 10 closed out — a net gain of 24 holders — while 37 added to existing stakes and 25 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $74.8M. The largest seller was Adage Capital Partners, cutting an estimated $15.5M.

  • 101 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q1 2015, up from 77 in Q4 2014.
  • Funds reported $1.01B of DIPLOMAT PHARMACY, INC. stock for Q1 2015, up 103% quarter-over-quarter.
  • 34 funds opened new DIPLOMAT PHARMACY, INC. positions in Q1 2015 and 10 closed out, a net change of +24 holders.
  • The largest DIPLOMAT PHARMACY, INC. buyer in Q1 2015 was Fidelity Investments, an estimated $74.8M added.
  • The largest DIPLOMAT PHARMACY, INC. seller in Q1 2015 was Adage Capital Partners, an estimated $15.5M sold.

Based on aggregated 13F filings for Q1 2015.